Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Frye

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depressionM A Frye, K A Gary, L B Marangell, et al.
Biological Psychiatry|February 13, 2001
Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorderT A Ketter, T A Kimbrell, M S George, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illnessP J Pazzaglia, R M Post, T A Ketter, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
The American Journal of Psychiatry|March 7, 2001
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorderS L McElroy, L L Altshuler, T Suppes, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. I. Rationale and methodsR M Post, W A Nolen, R W Kupka, et al.
Psychological Medicine|November 30, 2000
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illnessK D Denicoff, G S Leverich, W A Nolen, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depressionM A Frye, K A Gary, L B Marangell, et al.
Biological Psychiatry|February 13, 2001
Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorderT A Ketter, T A Kimbrell, M S George, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illnessP J Pazzaglia, R M Post, T A Ketter, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
The American Journal of Psychiatry|March 7, 2001
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorderS L McElroy, L L Altshuler, T Suppes, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. I. Rationale and methodsR M Post, W A Nolen, R W Kupka, et al.
Psychological Medicine|November 30, 2000
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illnessK D Denicoff, G S Leverich, W A Nolen, et al.
Pageof 8